Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pasithea Therapeutics Corp
KTTA
Healthcare
Biotechnology
Pasithea Therapeutics Corp. is a biotechnology company focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases. The Company is advancing a pipeline of three therapeutic product candidates, with a focus on its lead product candidate, PAS-004, a macrocyclic mitogen-activated protein kinase, or MEK inhibitor. PAS-004 is a...
small molecule allosteric inhibitor of MEK 1 and 2 (MEK 1/2) for potential use in the treatment of a range of RASopathies, including neurofibromatosis type 1 (NF1) and a number of oncology indications, among others. Its remaining two programs, PAS-001 and PAS-003, are in the earlier stages of development and are based on novel targets for the treatment of CNS disorders that it believes address limitations in the treatment paradigm of the indications it plans to address, which are amyotrophic lateral sclerosis (ALS) for its PAS-003 program, and schizophrenia for its PAS-001 program.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:KTTA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on May 20, 2025 7:01am
New Press Release - Pasithea Therapeutics Announces Preclinical Data that Shows PAS-004 Inhibits ETS2 Signaling, a Key Driver of Inflammation in IBD and Other Large Addressable Market Diseases
-- Demonstrates PAS-004’s potential as a differentiated MEK inhibitor for immune-mediated inflammatory diseases such as IBD and ankylosing spondylitis –-- Positions PAS-004 for potential expansion beyond MAPK pathway driven tumors into inflammatory diseases –-- PAS-004 outperforms FDA-approved...
read article.
•••
Jonathon Brown
X
Post by
Jonathon Brown
on May 15, 2025 8:58am
Buzz on the Bullboards: Quarterly reports and company mergers
This week also marks the heart of quarterly earnings season, when companies disclose their financial and operational performance.
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 14, 2025 7:02am
New Press Release - Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site
-- First patient expected to be dosed during Q2 2025 -- -- Trial will evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy in both plexiform neurofibromas and cutaneous neurofibromas -- -- Starting dose of 4mg tablet QD (once daily) -- -- First...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 07, 2025 5:00pm
New Press Release - Pasithea Therapeutics Announces Closing of $5 Million Public Offering
Additional Gross Proceeds of Approximately $1.3 Million Received Upon Exercise of Certain Warrants Issued in the Public Offering MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics, Corp. (“Pasithea,” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company...
read article.
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 07, 2025 9:47am
KTTA....One last word
Now trading at $1.27 this a.m I'd say you've all been Kyebaushed !!!!
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 11:39am
KTTA....now here is the only remedy available
to ease the huge loss that the Chasers & FOMO's have incurred. Wait for the next RS to be announced when the share price gets to sub 10 cents Good Luck.....TTYL in about 6 mos to a year
...more
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 11:34am
KTTA....Last person out... remember to turn out
the lights and make sure you don't let the door hit you in the a$$ when your leaving Cheers !
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 11:25am
KTTA....Halted again !!!!
There will be blood in the streets and tears in their Beers Isn't this the greatest system in the world ????? In a matter of 3 hrs u can go from Rags to Riches and back to the Poor house in a
...more
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 11:19am
KTTA ....NASDAQ Halt with code LUDP
Been halted for over the usual 5 min Looks like a $1.40 pricing on the financing....you're all f**ked
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 11:14am
KTTA....There u have Folks..... Financing was just announced
And u thought I was Full of **it !!!! It's halted now....last at $2.36 Let's see how many Chasers jump out of a window from the tallest building It's called the Greater Fool Theory
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 06, 2025 11:10am
New Press Release - Pasithea Therapeutics Announces Pricing of $5 Million Public Offering
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics, Corp. (“Pasithea,” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer...
read article.
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 10:39am
KTTA....154 million shares have traded...LoL
High of $3.79....Low of $2.00 I'd say ya gotta "Churn it....to Earn it...to Burn it" Whens the Financing announcement???? You will all be buried soon enough....wait for it ; )
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 9:46am
KTTA....58 million shares have traded
And that's all ya get??? Come on....what the float on this??? EDGAR S1... https://www.sec.gov/Archives/edgar/data/1841330/000121390025038088/ea0239642-s1_pasithea.htm
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 9:41am
KTTA ...u better run cause all those PM Chasers
want their money back LoL
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 9:11am
KTTA...Hmmm...doesn't anything ever "stick" ?
For some reason this was over $3 in early PM trading....now at $2.30 Sheesh...I wonder how many Greater Fools got buried with High Priced paper ???
(107)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2025 7:39am
KTTA....early a.m runner on News Release
I'm not a Dr. but.....this is a Phase 1 I tend to think that it's more about pumping the sh price up and raising Money Go ahead and fill yer boots...I'll watch from the sidelines with no
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Developing a sizeable copper resource with a highly prospective exploration asset in Peru
Identifying new compelling targets on extensive and highly prospective land position